Synthetic Biologics, Inc (NYSE:SYN), ended its previous trading session at $0.52 showing a loss of -0.02 or -2.25 percent with respect to the price of $0.54 when stock market opened. The company traded 75747 shares over the course of the trading day. Giving the average volume of 217.68 Million over the course of 3 consecutive months. Which signifies a pretty good change over the time with its shares outstanding of 17.8 Million.
Synthetic Biologics, Inc (NYSE:SYN) is currently trading lower than its price target which is set to $2.25 by the analyst. The stock is -38.35% Below its 1-Year High which is $0.85. SYN has a difference of 43.56% from its 1 year low which stands at $0.37. The company is currently rated by analyst who are keeping a close eye on the stock as 2. Where 1 means Buy, 2.5 meaning Hold and 5 as Sell.
Synthetic Biologics, Inc (NYSE:SYN) Performance Snapshot
The stock performed exceptionally bad in the previous week which depicts an decrease of -13.76 percent in the shares price. The company added about 5.73% in its share price over 1-Month. While taking about the performance of the stock over 1-year interval is -18 Percent. SYN currently shows 3.37% as its year to date performance.
Synthetic Biologics, Inc (NYSE:SYN) Price Insight
The stock needs to grow about $1.73 to reach its price target. In order to seek the stock’s directional movements, 20-Days, 50 Days and 200-Days moving averages are -3.07%, 5.36% and 7.63 percent respectively. The stock trades about 0.18 percent of its Float giving its total shares Outstanding are 17.8 Million. SYN gained about 29.38 percent in 6 months showing its Average True Range of 0.04. The company currently has a RSI and Beta of 49.68 and 1.99.
While talking about Synthetic Biologics, Inc (NYSE:SYN) valuation ratios, the stock trades with a P/S and P/B of 0 and 52.4 which is significantly better and attractive as compared to its peers.